HIGHLY STABLE EPIGENOME-WIDE PERIPHERAL BLOOD DNA METHYLATION SIGNATURES ACCURATELY PREDICT RESPONSE TO ADALIMUMAB, VEDOLIZUMAB AND USTEKINUMAB IN CROHN'S DISEASE PATIENTS
Joustra V., Yim AL., Hageman I., Levin E., Noble A., Chapman T., McGregor C., Adams A., Satsangi J., Henneman P., De Jonge W., D'Haens G.